Skip to main content

Change location

You are currently on the South Korea (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • South Korea (한국어)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • 재단
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT
      • Contrast agents

        • Iopamiro 300
        • Iopamiro 370
        • Iomeron 300
        • Iomeron 350
        • Iomeron 400
      • Medical devices

        • CT Exprès
        • Empower CTA +
    • MRI
      • Contrast agents

        • MultiHance Pre-filled Syringe
        • ProHance Injection
        • ProHance Pre-filled Syringe
      • Medical Devices

        • Empower MR
    • Ultrasound
      • Contrast agents

        • SonoVue
      • Software

        • VueBox
    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • Bracco Global Academy
    Education

    Learning, together.

    • Next-Gen Projects
    • Our Partnerships
  • Bracco sustainability report 2024
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Article
AIforCOVID: Predictive Diagnostics for Customizing COVID-19 Patient Treatments
The AIforCOVID initiative
Article
Drivers and barriers: Innovation in healthcare Alberto Spinazzi, Bracco Chief Medical and Regulatory Officer, answers some of these questions by illustrating future trends and the importance of prevention for human health.
Alberto Spinazzi interview
Page
Anti-corruption The Global Anti-Corruption Program provides guidance on how to conduct business in a fair, ethical, and legal manner and summarizes the laws and principles to which everyone working for the Bracco Group must adhere.
Bracco logo
Page
Quality Policies Bracco is committed to provide safe, reliable, effective products and services for the Patients and Customers through Quality excellence. The Quality organization has the appropriate level of independence and authority to act using the highest quality standards and promoting the quality culture company-wide.
No image available
Article
Bracco’s “The Beauty of Imaging” The multimedia installation explaining the importance of diagnostic imaging is now on display at STEP, to relate the future of radiology and precision medicine
Bracco’s “The Beauty of Imaging” lands back from Expo Dubai  at STEP FuturAbility District, Milan
Article
Bracco joins the UN Global Compact The UN Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption.
Bracco joins the United Nations Global Compact
Page
Whistleblowing Procedures and guidelines for Whistleblowing
Bracco logo
Article
The Impact of Seeing the Full Picture Bracco’s standpoint on sustainability - and environmental sustainability in particular - is that it is essential to look at the full picture.
Green forest
Article
Bracco announces the birth of Bracco Japan Ltd Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.
Bracco in Japan
Article
AI and Radiology: mutual game changers At ECR 2023 in Vienna, we discussed what means to be Gamechangers in radiology and how this aligns with the Bracco motto “Unlocking the Invisible”.
Intervista a EuSoMII
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182